|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.14 EUR | -2.73% |
|
-0.93% | +28.92% |
| Jul. 02 | Futures bearish; Lagarde confirms caution | AN |
| Jul. 01 | Mib and CAC the best after French vote | AN |
(Alliance News) - Arterra Bioscience Spa on Tuesday reported that its board of directors reviewed revenues as of September 30.
This came in at about EUR2.6 million, down 10 percent from the same period last year, when it was EUR2.9 million.
Arterra Bioscience on Tuesday is flat at EUR1.70 per share
By Maurizio Carta, Alliance News reporter
Comments and questions to redazione@alliancenews.com
Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.
Go to the original article.
Contact us to request a correctionLegal disclaimer
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 12,029 PTS | +0.19% | +1.47% | - | ||
| 2.14 EUR | -2.73% | -0.93% | 15.54M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +28.92% | 15.54M | |
| +22.10% | 46.55B | |
| +46.45% | 41.84B | |
| -3.12% | 40.84B | |
| +36.10% | 32.95B | |
| -6.30% | 28.27B | |
| +18.71% | 27.78B | |
| +46.15% | 14.26B | |
| +44.52% | 13.69B | |
| +0.19% | 12.18B |
ARTERRA BIOSCIENCE S.P.A. 
